Research ArticleTheranostics
PSMA-11–Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer
Ann-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, Mareike Roscher, Jana Schmidt, Esther Stenau, Tobias Simpfendörfer, Dogu Teber, Lena Maier-Hein, Boris Hadaschik, Uwe Haberkorn, Matthias Eder and Klaus Kopka
Journal of Nuclear Medicine April 2018, 59 (4) 639-645; DOI: https://doi.org/10.2967/jnumed.117.201293
Ann-Christin Baranski
1Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
Martin Schäfer
1Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
Ulrike Bauder-Wüst
1Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
Mareike Roscher
1Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
Jana Schmidt
1Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
Esther Stenau
2Division of Computer-Assisted Medical Interventions (CAMI), German Cancer Research Center (DKFZ), Heidelberg, Germany
Tobias Simpfendörfer
3Department of Urology, Heidelberg University Hospital, Heidelberg, Germany
Dogu Teber
3Department of Urology, Heidelberg University Hospital, Heidelberg, Germany
Lena Maier-Hein
2Division of Computer-Assisted Medical Interventions (CAMI), German Cancer Research Center (DKFZ), Heidelberg, Germany
Boris Hadaschik
4Department of Urology, University Hospital Essen, Essen, Germany
Uwe Haberkorn
5Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany
6Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
Matthias Eder
7Division of Radiopharmaceutical Development, German Cancer Consortium (DKTK), partner site Freiburg, and Department of Nuclear Medicine, University Medical Center, Freiburg, Germany; and
8German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
Klaus Kopka
1Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany
8German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 59, Issue 4
April 1, 2018
PSMA-11–Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer
Ann-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, Mareike Roscher, Jana Schmidt, Esther Stenau, Tobias Simpfendörfer, Dogu Teber, Lena Maier-Hein, Boris Hadaschik, Uwe Haberkorn, Matthias Eder, Klaus Kopka
Journal of Nuclear Medicine Apr 2018, 59 (4) 639-645; DOI: 10.2967/jnumed.117.201293
PSMA-11–Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer
Ann-Christin Baranski, Martin Schäfer, Ulrike Bauder-Wüst, Mareike Roscher, Jana Schmidt, Esther Stenau, Tobias Simpfendörfer, Dogu Teber, Lena Maier-Hein, Boris Hadaschik, Uwe Haberkorn, Matthias Eder, Klaus Kopka
Journal of Nuclear Medicine Apr 2018, 59 (4) 639-645; DOI: 10.2967/jnumed.117.201293
Jump to section
Related Articles
Cited By...
- Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells
- Rational Linker Design to Accelerate Excretion and Reduce Background Uptake of Peptidomimetic PSMA-Targeting Hybrid Molecules
- Cytoplasmic Localization of Prostate-Specific Membrane Antigen Inhibitors May Confer Advantages for Targeted Cancer Therapies
- Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye-Protein Interaction
- Trending: Radioactive and Fluorescent Bimodal/Hybrid Tracers as Multiplexing Solutions for Surgical Guidance
- Prostate-Specific Membrane Antigen-Guided Surgery
- A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for 18F-Immuno-PET and Fluorescence Imaging
- New Developments in Dual-Labeled Molecular Imaging Agents
- Entering the Era of Molecularly Targeted Precision Surgery in Recurrent Prostate Cancer
- Synthesis and Preclinical Characterization of the PSMA-Targeted Hybrid Tracer PSMA-I&F for Nuclear and Fluorescence Imaging of Prostate Cancer